OOS Investigations: What FDA Expects and Where Programs Break Down
Contact Us OOS Investigations: What FDA Expects and Where Programs Break Down An out-of-specification result is not itself a compliance failure. How you investigate it determines whether you have a defensible quality system or a vulnerability waiting to be cited. FDA’s guidance on investigating OOS laboratory test results, first issued in 2006 and still the … Read more